2010

EphrinA5 protein distribution in the developing mouse brain. BMC Neurosci., 2010, 11:105Deschamps C, Morel M, Janet T, Page G, Jaber M, Gaillard A, Prestoz L.

Time course of MPTP toxicity on translational control protein expression in mice brain. Toxicol Lett. 2010, 196(1):51-5.
Deguil J, Chavant F, Lafay-Chebassier C, Pérault-Pochat MC, Fauconneau B, Pain S.

Reduplication of an event after right caudate nucleus haemorrhage. Can J Neurol Sci, 2010, 37(4) : 468-72. (French)
Pluchon C, Salmon F, Houeto JL, Listrat A, Vandermarcq P, Gil R.

Alzheimer’s disease and impairment of the Self. Conscious Cogn, 2010, 19(4) : 969-76.
Fargeau MN, Jaafari N, Ragot S, Houeto JL, Pluchon C, Gil R.

Adjustments of conflict monitoring in Parkinson’s disease. Neuropsychology, 2010, 24(4) : 542-6.
Bonnin CA, Houeto JL, Gil R, Bouquet CA.

Imipramine, in part through TNF-alpha inhibition, prevents cognitive decline and Abeta accumulation in a mouse model of Alzheimer’s disease. J Pharmacol Exp Ther. 2010, 332(2):505-14.
Chavant F, Deguil J, Pain S, Ingrand I, Milin S, Fauconneau B, Perault MC, Lafay-Chebassier C.

Neuroprotective Effect of PACAP on Translational Control Alteration and Cognitive Decline in MPTP Parkinsonian Mice. Neurotox Res., 2010, 17(2):142-55
Deguil J, Chavant F, Lafay-Chebassier C, Pérault-Pochat MC, Fauconneau B, Pain S. .